To corroborate these results in vivo, we subcutaneously injected control, LAMC2-KD, as well as LAMC2-KD + EGFR A549 cells into 4-week-old male BALB/c-nude mice, and evaluated real-time tumor progression using fluorescence imaging (Fig. 4A). The gene discussed is EGFR; the disease is neoplasm.